Linked from

The 35 pages that link to Hematopoietic stem cell transplantation, each with the reason it gives.

• Immune systemRelated: It can rebuild immune-cell production after disease or intensive treatment.

• HematopoiesisRelated: Transplantation rebuilds hematopoiesis after marrow failure or intensive cancer treatment.

• Sickle cell diseaseRelated: Donor stem cells can restore blood production without sickle hemoglobin.

• Aplastic anemiaRelated: Allogeneic transplantation can cure severe aplastic anemia, particularly in suitable younger patients.

• CryopreservationRelated: Stem cells may be frozen before transplantation or intensive cancer treatment.

• LeukemiaRelated: Transplantation can provide durable disease control for selected high-risk or relapsed leukemias.

• Natural killer cellRelated: Donor NK cells can contribute to tumor control after transplantation.

• ImmunodeficiencyRelated: It can provide a durable correction for some severe immune-cell production defects.

• Severe combined immunodeficiencyRelated: It can establish durable immune function by providing healthy immune-cell precursors.

• Lysosomal storage diseaseRelated: Donor-derived cells can supply enzymes to some tissues in selected storage diseases.

• CyclophosphamideRelated: Cyclophosphamide is used in some transplant conditioning and post-transplant regimens.

• LeukodystrophyRelated: For selected leukodystrophies, early transplantation can slow disease progression.

• Acute radiation syndromeRelated: It has a limited role in severe marrow injury when supportive care cannot restore blood formation.

• Blood bankRelated: Transplant services rely on specialized compatibility testing and transfusion support.

• Chronic granulomatous diseaseRelated: It can provide a curative source of phagocytes with functional NADPH oxidase.

• OsteopetrosisRelated: For selected severe infantile cases, donor-derived osteoclasts can restore bone resorption.

• Primary immunodeficiencyRelated: It can rebuild immune function in severe disorders affecting multiple immune-cell lineages.

• HematologyRelated: It can restore blood formation after intensive treatment for selected blood cancers and marrow disorders.

• Krabbe diseaseRelated: Presymptomatic transplantation can slow disease progression in some affected infants, but does not reverse established damage.

• Metachromatic leukodystrophyRelated: In selected presymptomatic or early cases, donor-derived cells may slow neurological progression.

• AdrenoleukodystrophyRelated: It can halt early cerebral disease progression, but does not reverse established neurological damage.

• Fanconi anemiaRelated: It can treat severe marrow failure, though it does not remove the inherited cancer predisposition.

• Wiskott–Aldrich syndromeRelated: It can provide a lasting cure by establishing blood and immune cells with functional WAS protein.

• Bronchiolitis obliteransRelated: Chronic graft-versus-host disease after transplantation can involve bronchiolar injury.

• Diamond–Blackfan anemiaRelated: It can cure the marrow failure, but transplant risks and long-term effects require careful assessment.

• Farber diseaseRelated: It has been used in selected cases, though effects vary by disease manifestations.

• Hunter syndromeRelated: It has been explored for Hunter syndrome, but is not established standard therapy.

• Immune System DiseasesRelated: It can restore immune function in selected severe inherited disorders.